Skip to main content

Table 3 Sleep quality, depression, anxiety and medications between RLS- and RLS+

From: Restless legs syndrome in end stage renal disease patients undergoing hemodialysis

   Patients with ESRD, N (%)  
RLS- (n = 109) RLS+ (n = 28) P- value
PSQI   7 (4-10) 11 (5.25-13) 0.001
Sleep disorder   73 (67.0%) 25 (89.3%) 0.020
HADS-D   5 (1-9) 3 (1-7) 0.622
Depression No symptom 70 (64.2%) 22 (78.6%) 0.251
Suspicious 20 (18.3%) 1 (3.6%)  
Confirmed 19 (17.4%) 5 (17.9%)  
HADS-A   2 (0-4) 3 (1-6.5) 0.151
Anxiety No symptom 99 (91%) 25 (89.3%) 0.773
Suspicious 6 (5.5%) 1 (3.6%)  
Confirmed 4 (3.7%) 2 (7.1%)  
Medications Anti-anemia Medicine 85 (78.0%) 23 (82.1%) 0.631
Sedative hypnotics 10 (9.2%) 7 (25.0%) 0.047
  1. Abbreviations: ESRD end stage renal disease, RLS restless legs syndrome, RLS- without RLS, RLS+ with RLS, PSQI Pittsburgh Sleep Quality Index, HADS-D Hospital Anxiety and Depression Scale of Depression, HADS-A HADS-Anxiety